Bharat Immunologicals (India) Profile

16.15
INR 0.15  0.94%
74%
100%

Bharat Immunologicals Summary

Bharat Immunologicals Biologicals Corp Ltd (BIBCL) is traded on Bombay Stock Exchange in India. It is located in OPV Plant and employs 5 people. The company currently falls under 'Small-Cap' category with current market capitalization of 701.68 M. Bharat Immunologicals Biologicals Corp Ltd has 43.18 M outstanding shares.
Check Bharat Immunologicals Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 16.15HorizonTargetOdds Above 16.15
68.81%30 days 16.15 30.88%
Based on normal probability distribution, the odds of Bharat Immunologicals to move above current price in 30 days from now is about 30.88% (This Bharat Immunologicals Biologicals Corp Ltd probability density function shows the probability of Bharat Immunologicals Stock to fall within a particular range of prices over 30 days) .

Bharat Immunologicals Risk Profiles

Key Fundamentals

Bharat Immunologicals Against Markets

Current Ratings

Bharat Immunologicals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
17 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for Bharat Immunologicals Biologicals Corp Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. Bharat Immunologicals operates under Biotechnology classification in India and traded on Bombay Stock Exchange. more
NameBharat Immunologicals Biologicals Corp Ltd
Macroaxis Advice
InstrumentIndia Stock View All
Business AddressOPV Plant
ExchangeBombay Stock Exchange
SectorHealthcare
BenchmarkDOW
Websitewww.bibcol.com
Phone91 57 3223 8757
CurrencyINR
Check also Trending Equities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.